* Eyenovia Inc EYEN.OQ reported a quarterly adjusted loss
of 18
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -17
cents. The mean expectation of four analysts for the quarter
was for a loss of 17 cents per share. Wall Street expected
results to range from -22 cents to -15 cents per share.
* Revenue was $2.59 thousand; analysts expected $130.00
thousand.
* Eyenovia Inc's reported EPS for the quarter was a loss
of 18
cents.
* The company reported a quarterly loss of $7.97 million.
* Eyenovia Inc shares had fallen by 23.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 3.7%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is "buy."
Wall Street's median 12-month price target for Eyenovia Inc is
$10.00
This summary was machine generated from LSEG data March 18 at
10:19 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.17 -0.18 Missed
Sep. 30 2023 -0.18 -0.18 Met
Jun. 30 2023 -0.17 -0.16 Beat
Mar. 31 2023 -0.19 -0.15 Beat